INSULIN (HUMAN)

DRUG5 trials

Sponsors

Aarhus University Hospital, UZ Leuven, Hospital Clinico San Carlos

Conditions

Dry eye diseaseHyperglycemia in critically ill patients (stress hyperglycemia)Insulin resistancePersistent corneal epithelial defect.

Phase 2

Insulin Resistance and Statin Treatment in Renal Transplant Recipients and Patients with Chronic Kidney Disease

CompletedCTIS2022-501068-16-00

Aarhus University HospitalInsulin resistance

Start: 2022-12-14End: 2025-01-23Target: 30Updated: 2024-08-28

Phase 3

Impact of Tight blood Glucose Control within normal fasting ranges with insulin titration prescribed by the Leuven algorithm in adult critically ill patients.

Active, not recruitingCTIS2023-510358-17-00

UZ LeuvenHyperglycemia in critically ill patients (stress hyperglycemia)

Start: 2018-09-01Target: 9230Updated: 2024-10-02

Multicenter, controlled, randomized, observer-blinded clinical trial to evaluate the efficacy and safety of insulin eye drops (1 IU/ml) in the treatment of persistent corneal epithelial defect.

RecruitingCTIS2024-518818-53-00

Hospital Clinico San CarlosPersistent corneal epithelial defect.

Start: 2023-09-26Target: 234Updated: 2026-01-20

Phase 4

Clinical Trial To Determine The Efficacy And Safety Of Insulin Eye Drops In Dry Eye In Patients With Topical Hypotensors

Active, not recruitingCTIS2024-518407-22-00

Hospital Clinico San CarlosDry eye disease

Start: 2023-02-08Target: 100Updated: 2024-10-16

Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye

CompletedCTIS2024-518376-31-00

Hospital Clinico San CarlosDry eye disease

Start: 2022-10-19End: 2025-11-05Target: 120Updated: 2024-10-18